Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2015-06-26

First medicine recommended for approval for hidradenitis suppurativa

View source ↗

Summary

The EMA recommends the first medicine for approval to treat hidradenitis suppurativa, marking a landmark for this condition in Europe.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications